NCT00470574 arm group d4e12b4fc0a0c9cd66c692d59356f8d2 [clinicaltrials_resource:NCT00470574/arm-group/d4e12b4fc0a0c9cd66c692d59356f8d2]
QS21 [clinicaltrials_resource:039ab70422301b8c2163b25c612b786d]immunologic technique [clinicaltrials_resource:839c9cc4a63087a13957ff7fe090ade6]sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine [clinicaltrials_resource:9b6b60730fd3aa61881b40d1aaca6f0a]immunoenzyme technique [clinicaltrials_resource:bd42af09cd884e42840b1966fe0232d8]laboratory biomarker analysis [clinicaltrials_resource:dcf688170af1398473c3ebd2e11d5772]clinicaltrials:NCT00470574
arm group [clinicaltrials_vocabulary:arm-group]
NCT00470574 arm group d4e12b4fc0a0c9cd66c692d59356f8d2 [clinicaltrials_resource:NCT00470574/arm-group/d4e12b4fc0a0c9cd66c692d59356f8d2]
Bio2RDF identifier
NCT00470574/arm-group/d4e12b4fc0a0c9cd66c692d59356f8d2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... e12b4fc0a0c9cd66c692d59356f8d2
description [clinicaltrials_vocabulary:description]
Patients receive sialyl Lewisª ...... ts are followed every 3 months
identifier
clinicaltrials_resource:NCT00470574/arm-group/d4e12b4fc0a0c9cd66c692d59356f8d2
title
NCT00470574 arm group d4e12b4fc0a0c9cd66c692d59356f8d2
@en
type
label
NCT00470574 arm group d4e12b4f ...... 12b4fc0a0c9cd66c692d59356f8d2]
@en